Researchers Discover Tumor-Supressor Gene That May Indicate Susceptibility ToLung And Colon Cancer

October 08, 1998

DALLAS - Oct. 9, 1998 --- Discovery of a new human tumor-suppressor gene by UT Southwestern Medical Center at Dallas researchers could dramatically reduce the number of Americans who die annually from the two most lethal cancers, lung and colon malignancies.

Defining the PPP2R1B gene in human lung and colon cancer could make it possible for doctors to accurately predict who has a high risk of developing the two illnesses and find effective therapies for those already afflicted. The study is reported in today's journal Science by a team of investigators led by Dr. Glen Evans, director of the Eugene McDermott Center for Human Growth and Development at UT Southwestern, and Dr. Steven Wang, a postdoctoral fellow in the center.

"This finding is exciting because we have been able to locate, identify and determine the functions of this gene that is involved in lung and colon cancer and probably many others," said Evans, who also directs the Genome Science and Technology Center. "The mutations we found are both somatic and germline, in other words, found in both normal and tumor tissue. The significance of this evidence means the defect may be inherited, making some people more susceptible to cigarette smoke and similar tumor-promoting chemicals."

The American Cancer Society estimates that in 1998 nearly 48,000 people will die of colon cancer and 160,000 of lung cancer. Scientists already know that tumor promoters effect a biochemical process that is involved with phosphate metabolism.

PPP2R1B makes one of three proteins that removes phosphates from protein molecules that regulate cell growth. If the gene is not working correctly, too much phosphate builds up on the regulatory proteins, and the growth becomes uncontrolled. This unchecked cell division is the beginning of a tumor.

The researchers found PPP2R1B on chromosome 11 in an area they call a "hot spot" for cancer genes. They knew where to find the area because in many tumors a small section of chromosome or a gene is missing. This is called loss of heterozygosity (LOH).

Using a computer and gene sequences found through the international Human Genome Project, Wang checked about 100 genes in the LOH region until he found PPP2R1B, which appeared to be a cancer-suppressing gene, one that removes phosphates to control cell growth.

Next investigators used cells from people never diagnosed with cancer and from the normal tissue and the tumor tissue of cancer patients to test for mutations in PPP2R1B. They found that in the tumor tissue something had gone wrong with PPP2R1B so that additional phosphates were being added to the proteins allowing the cells to grow.

"If we can affect the amount of phosphates on these proteins through gene therapy or with a new drug, then we could arrest cell growth," said Evans, who holds the Eugene McDermott Distinguished Chair for the Study of Human Growth and Development. "We also now have the potential to predict who will get cancer from smoking and who won't."

The other researchers involved in this study included: Edward Esplin, UT Southwestern medical student and McDermott Center pre-doctoral student; Jia Ling Li, McDermott Center research scientist; Liying Huang, McDermott Center research assistant; Dr. Adi Gazdar, professor of pathology; and Dr. John Minna, director of the Nancy B. and Jake L. Hamon Center for Therapeutic Oncology Research and the W.A. "Tex" and Deborah Moncrief Jr. Center for Cancer Genetics.

This work was supported by the McDermott Center for Human Growth and Development, the National Institutes of Health, a National Cancer Institute Lung Cancer Specialized Program of Research Excellence grant and the UT Southwestern Medical Scientist Training Program.

To automatically receive news releases from UT Southwestern via e-mail, send a message to UTSWNEWS-REQUEST@listserv.swmed.edu. Leave the subject line blank and in the text box, type: SUB UTSWNEWS
-end-


UT Southwestern Medical Center

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.